Journal Of Tissue Engineering And Regenerative Medicine

Journal Title：Journal Of Tissue Engineering And Regenerative Medicine

Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed research papers, reviews, clinical case reports, perspectives, and short communications on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs.

The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership.

《组织工程与再生医学杂志》发表快速而严格的同行评审研究论文、评论、临床病例报告、观点和简短通讯，主题涉及结合干细胞或祖细胞、生物材料和支架、生长因子和其他生物活性剂及其各自构造的治疗方法的开发。所有论文都应涉及对组织和器官再生或修复的新临床方法的开发有直接或潜在影响的研究。

该杂志是多学科的，涵盖了生命科学和工程原理的结合，以推进医学和临床策略。该杂志侧重于使用细胞、材料和生化/机械因素来开发恢复、维持或改善组织或器官功能的生物功能替代品。该杂志发表关于任何组织或器官的研究，涵盖该领域的所有关键方面，包括新生物材料的开发和支架的加工；使用不同类型的细胞（主要是干细胞和祖细胞）及其在特定生物反应器中的培养；相关动物模型的研究；以及在严格的监管和道德框架下对人类患者进行的临床试验。描述使用先进方法表征工程组织的稿件也引起了期刊读者的特别兴趣。

Journal Of Tissue Engineering And Regenerative Medicine创刊于2007年，由John Wiley and Sons Ltd出版商出版，收稿方向涵盖生物 - 工程：生物医学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 偏慢,4-8周 ，影响因子指数3.1，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。